Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Non-intestinal type sinonasal cancers and exposure to occupational carcinogens: a case-control study.

Bonzini M, Facchinetti N, Zanetta L, Parassoni D, Borchini R, Battaglia P, Turri-Zanoni M, Castelnuovo P, Ferrario MM.

Med Lav. 2016 Sep 26;107(5):331-339. Italian.

PMID:
27681565
2.

Fate tracing reveals the endothelial origin of hematopoietic stem cells.

Zovein AC, Hofmann JJ, Lynch M, French WJ, Turlo KA, Yang Y, Becker MS, Zanetta L, Dejana E, Gasson JC, Tallquist MD, Iruela-Arispe ML.

Cell Stem Cell. 2008 Dec 4;3(6):625-36. doi: 10.1016/j.stem.2008.09.018.

3.

Hepatocyte-conditioned medium sustains endothelial differentiation of human hematopoietic-endothelial progenitors.

Bordoni V, Alonzi T, Zanetta L, Khouri D, Conti A, Corazzari M, Bertolini F, Antoniotti P, Pisani G, Tognoli F, Dejana E, Tripodi M.

Hepatology. 2007 May;45(5):1218-28.

PMID:
17464995
4.

A family based linkage analysis of HLA and 5-HTTLPR gene polymorphisms in Sardinian children with autism spectrum disorder.

Guerini FR, Manca S, Sotgiu S, Tremolada S, Zanzottera M, Agliardi C, Zanetta L, Saresella M, Mancuso R, De Silvestri A, Fois ML, Arru G, Ferrante P.

Hum Immunol. 2006 Jan-Feb;67(1-2):108-17. Epub 2006 Apr 6.

PMID:
16698432
5.

Downregulation of vascular endothelial-cadherin expression is associated with an increase in vascular tumor growth and hemorrhagic complications.

Zanetta L, Corada M, Grazia Lampugnani M, Zanetti A, Breviario F, Moons L, Carmeliet P, Pepper MS, Dejana E.

Thromb Haemost. 2005 Jun;93(6):1041-6.

PMID:
15968386
6.

Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells.

Rössig L, Urbich C, Brühl T, Dernbach E, Heeschen C, Chavakis E, Sasaki K, Aicher D, Diehl F, Seeger F, Potente M, Aicher A, Zanetta L, Dejana E, Zeiher AM, Dimmeler S.

J Exp Med. 2005 Jun 6;201(11):1825-35. Epub 2005 May 31.

7.

Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: a comparison with bone marrow progenitors, fibroblasts, and endothelial cells.

Galli D, Innocenzi A, Staszewsky L, Zanetta L, Sampaolesi M, Bai A, Martinoli E, Carlo E, Balconi G, Fiordaliso F, Chimenti S, Cusella G, Dejana E, Cossu G, Latini R.

Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):692-7. Epub 2005 Jan 20.

PMID:
15662021
8.

VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly.

Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ.

Blood. 2005 Apr 1;105(7):2771-6. Epub 2004 Dec 16.

9.

VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells.

Iurlaro M, Demontis F, Corada M, Zanetta L, Drake C, Gariboldi M, Peiro S, Cano A, Navarro P, Cattelino A, Tognin S, Marchisio PC, Dejana E.

Am J Pathol. 2004 Jul;165(1):181-9.

10.

Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis.

Spagnuolo R, Corada M, Orsenigo F, Zanetta L, Deuschle U, Sandy P, Schneider C, Drake CJ, Breviario F, Dejana E.

Blood. 2004 Apr 15;103(8):3005-12. Epub 2003 Dec 11.

11.

Skeletal myogenic progenitors in the endothelium of lung and yolk sac.

Cusella De Angelis MG, Balconi G, Bernasconi S, Zanetta L, Boratto R, Galli D, Dejana E, Cossu G.

Exp Cell Res. 2003 Nov 1;290(2):207-16.

PMID:
14567980
12.

A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability.

Corada M, Zanetta L, Orsenigo F, Breviario F, Lampugnani MG, Bernasconi S, Liao F, Hicklin DJ, Bohlen P, Dejana E.

Blood. 2002 Aug 1;100(3):905-11.

13.

c-abl is required for the development of hyperoxia-induced retinopathy.

Nunes I, Higgins RD, Zanetta L, Shamamian P, Goff SP.

J Exp Med. 2001 Jun 18;193(12):1383-91.

14.

Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.

Liao F, Li Y, O'Connor W, Zanetta L, Bassi R, Santiago A, Overholser J, Hooper A, Mignatti P, Dejana E, Hicklin DJ, Bohlen P.

Cancer Res. 2000 Dec 15;60(24):6805-10.

15.

Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis.

Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H, Eng K, Shamamian P, Mignatti P.

Int J Cancer. 2000 Jan 15;85(2):281-8.

16.

Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P.

EMBO J. 1997 May 1;16(9):2319-32.

Supplemental Content

Loading ...
Support Center